Integral Health Asset Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Integral Health Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$11.23 - $19.59 $1.4 Million - $2.45 Million	-125,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$13.37 - $17.79 $668,500 - $889,500	50,000 Added 66.67%	125,000 $2.03 Million
Q4 2021 Feb 02, 2022	BUY	$14.28 - $19.53 $1.07 Million - $1.46 Million	75,000 New	75,000 $1.22 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.